1-55058666-CGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT-CGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_174936.4(PCSK9):​c.1503+70_1503+71dupGT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 30 hom., cov: 0)
Exomes 𝑓: 0.0045 ( 4 hom. )

Consequence

PCSK9
NM_174936.4 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.20
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 1-55058666-C-CGT is Benign according to our data. Variant chr1-55058666-C-CGT is described in ClinVar as [Likely_benign]. Clinvar id is 928570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0187 (2662/142256) while in subpopulation SAS AF= 0.0232 (101/4362). AF 95% confidence interval is 0.0215. There are 30 homozygotes in gnomad4. There are 1228 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2662 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PCSK9NM_174936.4 linkc.1503+70_1503+71dupGT intron_variant ENST00000302118.5 NP_777596.2 Q8NBP7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PCSK9ENST00000302118.5 linkc.1503+19_1503+20insGT intron_variant 1 NM_174936.4 ENSP00000303208.5 Q8NBP7-1

Frequencies

GnomAD3 genomes
AF:
0.0187
AC:
2658
AN:
142178
Hom.:
30
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0228
Gnomad AMI
AF:
0.00341
Gnomad AMR
AF:
0.00961
Gnomad ASJ
AF:
0.0295
Gnomad EAS
AF:
0.000631
Gnomad SAS
AF:
0.0227
Gnomad FIN
AF:
0.00733
Gnomad MID
AF:
0.0203
Gnomad NFE
AF:
0.0208
Gnomad OTH
AF:
0.0149
GnomAD4 exome
AF:
0.00453
AC:
6264
AN:
1382268
Hom.:
4
Cov.:
0
AF XY:
0.00479
AC XY:
3282
AN XY:
685196
show subpopulations
Gnomad4 AFR exome
AF:
0.00741
Gnomad4 AMR exome
AF:
0.00408
Gnomad4 ASJ exome
AF:
0.00962
Gnomad4 EAS exome
AF:
0.00157
Gnomad4 SAS exome
AF:
0.00986
Gnomad4 FIN exome
AF:
0.00350
Gnomad4 NFE exome
AF:
0.00400
Gnomad4 OTH exome
AF:
0.00604
GnomAD4 genome
AF:
0.0187
AC:
2662
AN:
142256
Hom.:
30
Cov.:
0
AF XY:
0.0178
AC XY:
1228
AN XY:
68908
show subpopulations
Gnomad4 AFR
AF:
0.0228
Gnomad4 AMR
AF:
0.00960
Gnomad4 ASJ
AF:
0.0295
Gnomad4 EAS
AF:
0.000633
Gnomad4 SAS
AF:
0.0232
Gnomad4 FIN
AF:
0.00733
Gnomad4 NFE
AF:
0.0208
Gnomad4 OTH
AF:
0.0148

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpDec 09, 2019Variant summary: PCSK9 c.1503+68_1503+69dupGT is located at a position not widely known to affect splicing. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.019 in 24890 control chromosomes, predominantly at a frequency of 0.024 within the African or African-American subpopulation in the gnomAD database, including 10 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 256-folds over the estimated maximal expected allele frequency for a pathogenic variant in PCSK9 causing Familial Hypercholesterolemia phenotype (9.4e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.1503+68_1503+69dupGT in individuals affected with Familial Hypercholesterolemia and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -
Hypercholesterolemia, autosomal dominant, 3 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 13, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35115360; hg19: chr1-55524339; API